FUT7 Promotes the Epithelial–Mesenchymal Transition and Immune Infiltration in Bladder Urothelial Carcinoma

References

• van Wilpe S, Gerretsen ECF, van der Heijden AG, de Vries IJM, Gerritsen WR, Mehra N. Prognostic and predictive value of tumor-infiltrating immune cells in urothelial cancer of the bladder. Cancers (Basel). 2020;12(9):E2692. doi:10.3390/cancers12092692
   PubMed Web of Science ®Google Scholar
• Zangouei AS, Barjasteh AH, Rahimi HR, Mojarrad M, Moghbeli M. Role of tyrosine kinases in bladder cancer progression: an overview. Cell Commun Signal. 2020;18(1):127. doi:10.1186/s12964-020-00625-7
   PubMed Web of Science ®Google Scholar
• Chen WQ, Zheng RS, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.21338
   PubMed Web of Science ®Google Scholar
• Patel VG, Oh WK, Galsky MD. Treatment of muscle-invasive and advanced bladder cancer in 2020. CA Cancer J Clin. 2020;70(5):404–423. doi:10.3322/caac.21631
   PubMed Web of Science ®Google Scholar
• Witjes JA, Bruins HM, Cathomas R, et al. European association of urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines. Eur Urol. 2020;79(1):82–104.
   PubMed Web of Science ®Google Scholar
• Knowles MA, Hurst CD. Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity. Nat Rev Cancer. 2015;15(1):25–41. doi:10.1038/nrc3817
   PubMed Web of Science ®Google Scholar
• Alfred witjes J, Lebret T, Compérat EM, et al. Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol. 2017;71(3):462–475.
   PubMed Web of Science ®Google Scholar
• Sanli O, Dobruch J, Knowles MA, et al. Bladder cancer. Nat Rev Dis Primers. 2017;3:17022. doi:10.1038/nrdp.2017.22
   PubMed Web of Science ®Google Scholar
• Ng K, Stenzl A, Sharma A, Vasdev N. Urinary biomarkers in bladder cancer: a review of the current landscape and future directions. Urol Oncol. 2020;39(1):41–51.
   PubMed Web of Science ®Google Scholar
• Yang Y, Liu C, Yang X. Endoscopic molecular imaging plus photoimmunotherapy: a new strategy for monitoring and treatment of bladder cancer. Mol Ther Oncolytics. 2020;18:409–418. doi:10.1016/j.omto.2020.07.010
   PubMed Web of Science ®Google Scholar
• Afonso J, Santos LL, Longatto-Filho A, Baltazar F. Competitive glucose metabolism as a target to boost bladder cancer immunotherapy. Nat Rev Urol. 2020;17(2):77–106. doi:10.1038/s41585-019-0263-6
   PubMed Web of Science ®Google Scholar
• Rasheduzzaman M, Kulasinghe A, Dolcetti R, et al. Protein glycosylation in head and neck cancers: from diagnosis to treatment. Biochim Biophys Acta Rev Cancer. 2020;1874(2):188422. doi:10.1016/j.bbcan.2020.188422
   PubMed Web of Science ®Google Scholar
• Moffett S, Shiao TC, Mousavifar L, Mignani S, Roy R. Aberrant glycosylation patterns on cancer cells: therapeutic opportunities for glycodendrimers/metallodendrimers oncology. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020;13(1):e1659. doi:10.1002/wnan.1659
   PubMed Web of Science ®Google Scholar
• Council CE, Kilpin KJ, Gusthart JS, Allman SA, Linclau B, Lee SS. Enzymatic glycosylation involving fluorinated carbohydrates. Org Biomol Chem. 2020;18(18):3423–3451. doi:10.1039/D0OB00436G
   PubMed Web of Science ®Google Scholar
• Rudman N, Gornik O, Lauc G. Altered N-glycosylation profiles as potential biomarkers and drug targets in diabetes. FEBS Lett. 2019;593(13):1598–1615. doi:10.1002/1873-3468.13495
   PubMed Web of Science ®Google Scholar
• Du T, Jia X, Dong X, et al. Cosmc disruption-mediated aberrant O-glycosylation suppresses breast cancer cell growth via impairment of CD44. Cancer Manag Res. 2020;12:511–522. doi:10.2147/CMAR.S234735
   PubMed Web of Science ®Google Scholar
• Zhang J, Ten Dijke P, Wuhrer M, Zhang T. Role of glycosylation in TGF-β signaling and epithelial-to-mesenchymal transition in cancer. Protein Cell. 2020. doi:10.1007/s13238-020-00741-7
   Web of Science ®Google Scholar
• Chandler KB, Costello CE, Rahimi N. Glycosylation in the tumor microenvironment: implications for tumor angiogenesis and metastasis. Cells. 2019;8(6):544. doi:10.3390/cells8060544
   PubMed Web of Science ®Google Scholar
• Pan J, Hu Y, Sun S, et al. Glycoproteomics-based signatures for tumor subtyping and clinical outcome prediction of high-grade serous ovarian cancer. Nat Commun. 2020;11(1):6139. doi:10.1038/s41467-020-19976-3
   PubMed Web of Science ®Google Scholar
• Wu ZL, Whitaker M, Person AD, Kalabokis V. Detecting substrate glycans of fucosyltransferases with fluorophore-conjugated fucose and methods for glycan electrophoresis. Glycobiology. 2020;30(12):970–980. doi:10.1093/glycob/cwaa030
   PubMed Web of Science ®Google Scholar
• Pink M, Ratsch BA, Mardahl M, et al. Imprinting of skin/inflammation homing in CD4+ T cells is controlled by DNA methylation within the Fucosyltransferase 7 gene. J Immunol. 2016;197(8):3406–3414. doi:10.4049/jimmunol.1502434
   PubMed Web of Science ®Google Scholar
• Li D, Sun H, Bai G, et al. α-1,3-Fucosyltransferase-VII siRNA inhibits the expression of SLex and hepatocarcinoma cell proliferation. Int J Mol Med. 2018;42(5):2700–2708. doi:10.3892/ijmm.2018.3850
   PubMed Web of Science ®Google Scholar
• Jassam SA, Maherally Z, Ashkan K, Pilkington GJ, Fillmore HL. Fucosyltransferase 4 and 7 mediates adhesion of non-small cell lung cancer cells to brain-derived endothelial cells and results in modification of the blood-brain-barrier: in vitro investigation of CD15 and CD15s in lung-to-brain metastasis. J Neurooncol. 2019;143(3):405–415. doi:10.1007/s11060-019-03188-x
   PubMed Web of Science ®Google Scholar
• Liang JX, Gao W, Cai L. Fucosyltransferase VII promotes proliferation via the EGFR/AKT/mTOR pathway in A549 cells. Onco Targets Ther. 2017;10:3971–3978. doi:10.2147/OTT.S140940
   PubMed Web of Science ®Google Scholar
• Qin H, Liu J, Yu M, et al. FUT7 promotes the malignant transformation of follicular thyroid carcinoma through α1,3-fucosylation of EGF receptor. Exp Cell Res. 2020;393(2):112095. doi:10.1016/j.yexcr.2020.112095
   PubMed Web of Science ®Google Scholar
• Song X, Zhou Z, Li H, et al. Pharmacological suppression of B7-H4 glycosylation restores antitumor immunity in immune-cold breast cancers. Cancer Discov. 2020;10(12):1872–1893. doi:10.1158/2159-8290.CD-20-0402
   PubMed Web of Science ®Google Scholar
• Wang Y, Li Q, Niu L, et al. Suppression of G6PD induces the expression and bisecting GlcNAc-branched N-glycosylation of E-Cadherin to block epithelial-mesenchymal transition and lymphatic metastasis. Br J Cancer. 2020;123(8):1315–1325. doi:10.1038/s41416-020-1007-3
   PubMed Web of Science ®Google Scholar
• Zahradnikova M, Ihnatova I, Lattova E, et al. N-Glycome changes reflecting resistance to platinum-based chemotherapy in ovarian cancer. J Proteomics. 2020;230:103964. doi:10.1016/j.jprot.2020.103964
   PubMed Web of Science ®Google Scholar
• Legler K, Rosprim R, Karius T, et al. Reduced mannosidase MAN1A1 expression leads to aberrant N-glycosylation and impaired survival in breast cancer. Br J Cancer. 2018;118(6):847–856. doi:10.1038/bjc.2017.472
   PubMed Web of Science ®Google Scholar
• Zhang G, Lu J, Yang M, Wang Y, Liu H, Xu C. Elevated GALNT10 expression identifies immunosuppressive microenvironment and dismal prognosis of patients with high grade serous ovarian cancer. Cancer Immunol Immunother. 2020;69(2):175–187. doi:10.1007/s00262-019-02454-1
   PubMed Web of Science ®Google Scholar
• Deb B, Patel K, Sathe G, Kumar P. N-glycoproteomic profiling reveals alteration in extracellular matrix organization in non-type bladder carcinoma. J Clin Med. 2019;8(9):1303. doi:10.3390/jcm8091303
   PubMed Web of Science ®Google Scholar
• Li C, Du Y, Yang Z, et al. GALNT1-mediated glycosylation and activation of sonic hedgehog signaling maintains the self-renewal and tumor-initiating capacity of bladder cancer stem cells. Cancer Res. 2016;76(5):1273–1283. doi:10.1158/0008-5472.CAN-15-2309
   PubMed Web of Science ®Google Scholar
• Wahby S, Jarczyk J, Fierek A, et al. POFUT1 mRNA expression as an independent prognostic parameter in muscle-invasive bladder cancer. Transl Oncol. 2021;14(1):100900. doi:10.1016/j.tranon.2020.100900
   PubMed Web of Science ®Google Scholar
• Zheng Q, Zhang D, Yang YU, et al. MicroRNA-200c impairs uterine receptivity formation by targeting FUT4 and α1,3-fucosylation. Cell Death Differ. 2017;24(12):2161–2172. doi:10.1038/cdd.2017.136
   PubMed Web of Science ®Google Scholar
• Zhang YM, Zhang YY, Bulbul A, Shan X, Wang XQ, Yan Q. Baicalin promotes embryo adhesion and implantation by upregulating fucosyltransferase IV (FUT4) via Wnt/beta-catenin signaling pathway. FEBS Lett. 2015;589(11):1225–1233. doi:10.1016/j.febslet.2015.04.011
   PubMed Web of Science ®Google Scholar
• Lu HH, Lin SY, Weng RR, et al. Fucosyltransferase 4 shapes oncogenic glycoproteome to drive metastasis of lung adenocarcinoma. EBioMedicine. 2020;57:102846. doi:10.1016/j.ebiom.2020.102846
   PubMed Web of Science ®Google Scholar
• Dai Y, Cheng Z, Pang Y, et al. Prognostic value of the FUT family in acute myeloid leukemia. Cancer Gene Ther. 2020;27(1–2):70–80. doi:10.1038/s41417-019-0115-9
   PubMed Web of Science ®Google Scholar
• Yang H, Kuo YH, Smith ZI, Spangler J. Targeting cancer metastasis with antibody therapeutics. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021;e1698. doi:10.1002/wnan.1698
   PubMed Web of Science ®Google Scholar
• He C, Li A, Lai Q, et al. The DDX39B/FUT3/TGFbetaR-I axis promotes tumor metastasis and EMT in colorectal cancer. Cell Death Dis. 2021;12(1):74. doi:10.1038/s41419-020-03360-6
   PubMed Web of Science ®Google Scholar
• Mola S, Pandolfo C, Sica A, Porta C. The macrophages-microbiota interplay in colorectal cancer (CRC)-related inflammation: prognostic and therapeutic significance. Int J Mol Sci. 2020;21(18):E6866. doi:10.3390/ijms21186866
   PubMed Web of Science ®Google Scholar
• Chen M, Hu C, Gao Q, et al. Study on metastasis inhibition of Kejinyan decoction on lung cancer by affecting tumor microenvironment. Cancer Cell Int. 2020;20:451. doi:10.1186/s12935-020-01540-0
   PubMed Web of Science ®Google Scholar
• Rabold K, Aschenbrenner A, Thiele C, et al. Enhanced lipid biosynthesis in human tumor-induced macrophages contributes to their protumoral characteristics. J Immunother Cancer. 2020;8(2):e000638. doi:10.1136/jitc-2020-000638
   PubMed Web of Science ®Google Scholar
• Trimaglio G, Tilkin-Mariamé AF, Feliu V, et al. Colon-specific immune microenvironment regulates cancer progression versus rejection. Oncoimmunology. 2020;9(1):1790125. doi:10.1080/2162402X.2020.1790125
   PubMed Web of Science ®Google Scholar
• Oshi M, Asaoka M, Tokumaru Y, et al. CD8 T cell score as a prognostic biomarker for triple negative breast cancer. Int J Mol Sci. 2020;21(18):E6968.
   PubMed Web of Science ®Google Scholar
• Tang J, Ramis-Cabrer D, Curull V, et al. B cells and tertiary lymphoid structures influence survival in lung cancer patients with resectable tumors. Cancers (Basel). 2020;12(9):E2644. doi:10.3390/cancers12092644
   PubMed Web of Science ®Google Scholar
• Li BL, Wan XP. Prognostic significance of immune landscape in tumour microenvironment of endometrial cancer. J Cell Mol Med. 2020;24(14):7767–7777. doi:10.1111/jcmm.15408
   PubMed Web of Science ®Google Scholar
• Xiang Z, Zhou Q, Zeng H, et al. Intratumoral CCR5 + neutrophils identify immunogenic subtype muscle-invasive bladder cancer with favorable prognosis and therapeutic responses. Oncoimmunology. 2020;9(1):1802176.
   PubMed Web of Science ®Google Scholar
• Wang Z, Zhao Y, Xu H, et al. CtBP1 promotes tumour-associated macrophage infiltration and progression in non-small-cell lung cancer. J Cell Mol Med. 2020;24(19):11445–11456. doi:10.1111/jcmm.15751
   PubMed Web of Science ®Google Scholar
• Tekin C, Aberson HL, Waasdorp C, et al. Macrophage-secreted MMP9 induces mesenchymal transition in pancreatic cancer cells via PAR1 activation. Cell Oncol (Dordr). 2020;43(6):1161–1174. doi:10.1007/s13402-020-00549-x
   PubMed Web of Science ®Google Scholar
• El Khoury LY, Fu S, Hlady RA, et al. Identification of DNA methylation signatures associated with poor outcome in lower-risk stage, size, grade and necrosis (SSIGN) score clear cell renal cell cancer. Clin Epigenetics. 2021;13(1):12. doi:10.1186/s13148-020-00998-z
   PubMed Web of Science ®Google Scholar
• Jin L, Cai Q, Wang S, Wang S, Wang J, Quan Z. Long noncoding RNA PVT1 promoted gallbladder cancer proliferation by epigenetically suppressing miR-18b-5p via DNA methylation. Cell Death Dis. 2020;11(10):871. doi:10.1038/s41419-020-03080-x
   PubMed Web of Science ®Google Scholar
• Yang W, Li L, Zhang K, et al. CLDN10 associated with immune infiltration is a novel prognostic biomarker for clear cell renal cell carcinoma. Epigenomics. 2020. doi:10.2217/epi-2020-0256
   Web of Science ®Google Scholar